These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26453937)
1. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Martínez-Revollar G; Garay E; Martin-Tapia D; Nava P; Huerta M; Lopez-Bayghen E; Meraz-Cruz N; Segovia J; González-Mariscal L Exp Cell Res; 2015 Nov; 339(1):67-80. PubMed ID: 26453937 [TBL] [Abstract][Full Text] [Related]
2. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor. Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298 [TBL] [Abstract][Full Text] [Related]
3. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells. Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138 [TBL] [Abstract][Full Text] [Related]
4. Combination of SF1126 and gefitinib induces apoptosis of triple-negative breast cancer cells through the PI3K/AKT-mTOR pathway. Deng M; Wang J; Chen Y; Zhang L; Liu D Anticancer Drugs; 2015 Apr; 26(4):422-7. PubMed ID: 25588160 [TBL] [Abstract][Full Text] [Related]
5. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
6. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression. Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422 [TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells]. Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477 [TBL] [Abstract][Full Text] [Related]
8. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity. Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799 [TBL] [Abstract][Full Text] [Related]
9. Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway. He K; Xu T; Xu Y; Ring A; Kahn M; Goldkorn A Int J Cancer; 2014 Jan; 134(1):43-54. PubMed ID: 23784558 [TBL] [Abstract][Full Text] [Related]
10. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes. Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017 [TBL] [Abstract][Full Text] [Related]
11. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway. Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089 [TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Baryawno N; Sveinbjörnsson B; Eksborg S; Chen CS; Kogner P; Johnsen JI Cancer Res; 2010 Jan; 70(1):266-76. PubMed ID: 20028853 [TBL] [Abstract][Full Text] [Related]
13. Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells. Shrivastava S; Kulkarni P; Thummuri D; Jeengar MK; Naidu VG; Alvala M; Redddy GB; Ramakrishna S Apoptosis; 2014 Jul; 19(7):1148-64. PubMed ID: 24729100 [TBL] [Abstract][Full Text] [Related]
14. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587 [TBL] [Abstract][Full Text] [Related]
15. TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β-Catenin Pathway upon LPS Stimulation. Li J; Yin J; Shen W; Gao R; Liu Y; Chen Y; Li X; Liu C; Xiang R; Luo N Anat Rec (Hoboken); 2017 Jul; 300(7):1219-1229. PubMed ID: 28296189 [TBL] [Abstract][Full Text] [Related]
16. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway. Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885 [TBL] [Abstract][Full Text] [Related]
17. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer. Liu J; Chen X; Ward T; Pegram M; Shen K Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188 [TBL] [Abstract][Full Text] [Related]
18. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer. Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678 [TBL] [Abstract][Full Text] [Related]
19. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways. Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610 [TBL] [Abstract][Full Text] [Related]
20. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma. Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]